VelocityEHS Virtual Course on Bowtie Analysis Helps Attendees Manage Operational Risks
CHICAGO, Feb. 16, 2023 (GLOBE NEWSWIRE) — VelocityEHS, the global leader in enterprise EHS &…
CHICAGO, Feb. 16, 2023 (GLOBE NEWSWIRE) — VelocityEHS, the global leader in enterprise EHS &…
Toronto, Ontario–(Newsfile Corp. – February 16, 2023) – EarthLabs Inc. (TSXV: SPOT) (OTCQX: SPOFF) (“EarthLabs”…
ABU DHABI, UAE, Feb 17, 2023 – (ACN Newswire) – Verofax, the leading MarTech solution…
BENGALURU, INDIA, Feb 16, 2023 – (ACN Newswire) – Trescon prides itself on its unwavering…
Top Cybersecurity Professionals from 50 Nations Recognized for their Industry Accomplishments and Excellence as Ethical…
Top smart apartment innovator Quext further bolsters patent protection around its differentiated IoT solution –…
Khan Will Join Fellow Procurement Leaders from ExxonMobil, Uber, DoorDash, IBM (and More) to Explore…
Goizueta Institute @Emory Brain Health and The Seavey Clinic Collaborating on Use of Digital Cognitive…
Insight-commissioned survey documents the current state of digital-first initiatives. CHANDLER, Ariz.–(BUSINESS WIRE)–An overwhelming majority of…
Scientists Can Now Begin the mRNA Synthesis Process from Their Own Sequence or Plasmid DNA…
Average bioavailability greater than 50% with high consistency observed in animal study SAN DIEGO, Feb….
CINCINNATI–(BUSINESS WIRE)–DOCS Dermatology, (“DOCS” or the “Company”), one of the largest dermatology management platforms in…
Results from the Phase 3 MAGNITUDE study second interim analysis to be featured in an…
Results demonstrate the potential benefit of vaccinating donors with Triplex to enhance CMV protective immunity…
HOUSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
– 513(g) submission will allow Intelligent Bio Solutions Inc. to determine the most suitable FDA…
– Experienced biotech executive brings more than 20 years of financial leadership to Vir –…
Topline Data from ZETA-1 Phase 2 Trial of Oral APX3330 in Diabetic Retinopathy Presented on…
WATERTOWN, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) — Disc Medicine, a clinical-stage biopharmaceutical company focused…
BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company…